We are live on
!
Find out more
VF
Virtu Financial Portfolio holdings
AUM
$3.18B
Turnover
77.45%
1-Year Est. Return
65.92%
This Fund
S&P 500
This Quarter
Est. Return
+4.12%
1 Year Est. Return
+65.92%
3 Year Est. Return
+160.27%
5 Year Est. Return
+179.96%
10 Year Est. Return
–
AUM
$2.02B
AUM Growth
+$1.3B
(+180%)
Cap. Flow
+$1.27B
Cap. Flow
% of AUM
62.76%
Top 10 Holdings %
Top 10 Hldgs %
16.65%
Holding
2,553
New
2,160
Increased
164
Reduced
123
Closed
87
Avg Time Held Equity + Options
0.1
years
Top 10 Avg Time Held Equity + Options
0.2
years
Top 20 Avg Time Held Equity + Options
0.2
years
Avg Time Held Equity only
0.1
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$40.3M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$21M |
| 3 |
ProShares Short VIX Short-Term Futures ETF
SVXY
|
+$19.2M |
| 4 |
AF
Astoria Financial Corporation
AF
|
+$18.7M |
| 5 |
State Street DoubleLine Total Return Tactical ETF
TOTL
|
+$16.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$24.8M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$18.6M |
| 3 |
OKS
Oneok Partners LP
OKS
|
+$15.5M |
| 4 |
ProShares Short S&P500
SH
|
+$9.57M |
| 5 |
Invesco CurrencyShares British Pound Sterling Trust
FXB
|
+$7.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 57.39% |
| 2 | Financials | 7.24% |
| 3 | Consumer Discretionary | 7% |
| 4 | Healthcare | 6.56% |
| 5 | Technology | 4.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2351
DELISTED
Meta Materials Inc. Common Stock
MMAT
| $20K | ﹤0.01% |
+80
| New | +$20.9K |
2017 Q3
0 quarters
|
|
|
SRUNW
2352
DELISTED
Silver Run Acquisition Corporation II
SRUNW
| $20K | ﹤0.01% |
+13,475
| New | +$22.3K |
2017 Q3
0 quarters
|
|
2353
Can-Fite BioPharma American Depositary Shares
CANF
$3.96M
| $19K | ﹤0.01% |
+4
| New | +$20.6K |
2017 Q3
0 quarters
|
|
2354
Kiora Pharmaceuticals
KPRX
$10.7M
| $19K | ﹤0.01% |
+3
| New | +$19.1K |
2017 Q3
0 quarters
|
|
|
PWCM
2355
PowerCompute Inc
PWCM
$1.2M
| $19K | ﹤0.01% |
+1
| New | +$23.5K |
2017 Q3
0 quarters
|
|
2356
CPI Card Group
PMTS
$298M
| $19K | ﹤0.01% |
+3,183
| New | +$27.6K |
2017 Q3
0 quarters
|
|
2357
Fabric.AI Inc
FABC
$15.4M
| $18K | ﹤0.01% |
+1
| New | +$20K |
2017 Q3
0 quarters
|
|
2358
Cineverse
CNVS
$39.9M
| $18K | ﹤0.01% |
+610
| New | +$18.5K |
2017 Q3
0 quarters
|
|
2359
Quest Resource Holding
QRHC
$25.1M
| $18K | ﹤0.01% |
+15,699
| New | +$24.9K |
2017 Q3
0 quarters
|
|
2360
RENN Fund
RCG
$19.8M
| $18K | ﹤0.01% |
+12,638
| New | +$17K |
2017 Q3
0 quarters
|
|
2361
DELISTED
Avinger, Inc. Common Stock
AVGR
| – | – |
0
| – | – |
2017 Q3
0 quarters
|
|
|
EMX
2362
DELISTED
EMX Royalty
EMX
| $17K | ﹤0.01% |
+20,503
| New | +$19.3K |
2017 Q3
0 quarters
|
|
2363
DELISTED
Hepion Pharmaceuticals
HEPA
| – | – |
0
| – | – |
2017 Q3
0 quarters
|
|
2364
Harte-Hanks
HHS
$32.3M
| $17K | ﹤0.01% |
+1,583
| New | +$14.6K |
2017 Q3
0 quarters
|
|
2365
Neonode
NEON
$13.4M
| $17K | ﹤0.01% |
+1,359
| New | +$15.6K |
2017 Q3
0 quarters
|
|
2366
XMAX Inc
XMAX
$550M
| $17K | ﹤0.01% |
+410
| New | +$14.3K |
2017 Q3
0 quarters
|
|
2367
Protalix BioTherapeutics
PLX
$218M
| $17K | ﹤0.01% |
+2,946
| New | +$18.9K |
2017 Q3
0 quarters
|
|
2368
SiNtx Technologies
SINT
$13.4M
| – | – |
0
| – | – |
2017 Q3
0 quarters
|
|
2369
Ur-Energy
URG
$356M
| $17K | ﹤0.01% |
+28,698
| New | +$17.4K |
2017 Q3
0 quarters
|
|
|
IDSA
2370
DELISTED
Industrial Services of America
IDSA
| $17K | ﹤0.01% |
+10,409
| New | +$17.4K |
2017 Q3
0 quarters
|
|
2371
DELISTED
Christopher & Banks Corporation
CBK
| $17K | ﹤0.01% |
+12,362
| New | +$17.1K |
2017 Q3
0 quarters
|
|
2372
DELISTED
Bank Of America Corporation Ws B
BAC.WS.B
| $17K | ﹤0.01% |
+21,722
| New | +$15.9K |
2017 Q3
0 quarters
|
|
2373
FF EAI Robotics Ecosystem Inc. Common Stock
FFR
$22.4M
| – | – |
0
| – | – |
2017 Q3
0 quarters
|
|
2374
TuHURA Biosciences
HURA
$117M
| $16K | ﹤0.01% |
+1
| New | +$27.4K |
2017 Q3
0 quarters
|
|
|
OCRX
2375
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $16K | ﹤0.01% |
+14,281
| New | +$15.3K |
2017 Q3
0 quarters
|
|
Similar funds
GM
TA
CI
GIA
NSLI
Virtu Financial's Q3 2017 Portfolio in Review
As of Q3 2017, Virtu Financial held 2,553 positions worth $2.02B, up 180% from $721M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Virtu Financial deployed $1.27B of net new capital in Q3 2017, opening 2,160 new positions and adding to 164 existing holdings. Its largest new stake was State Street DoubleLine Total Return Tactical ETF: 338,092 shares worth $16.7M.
By sector, the portfolio is most concentrated in Miscellaneous at 57% of assets, down from 79% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $24.8M trimmed.
- Virtu Financial's largest Q3 2017 buy was State Street DoubleLine Total Return Tactical ETF: 338,092 shares worth $16.7M.
- Virtu Financial added most to VanEck Gold Miners ETF in Q3 2017, an estimated $40.3M increase.
- Virtu Financial's biggest Q3 2017 reduction was Vanguard S&P 500 ETF, cutting an estimated $24.8M.
- Virtu Financial fully exited Oneok Partners LP in Q3 2017, selling an estimated $15.5M.
- Virtu Financial's ten largest holdings make up 17% of its $2.02B portfolio in Q3 2017.
- Virtu Financial opened 2,160 new positions and closed 87 in Q3 2017.
- Virtu Financial's portfolio value rose 180% quarter-over-quarter to $2.02B.
Based on Virtu Financial's 13F filing for Q3 2017, filed 15 Nov 2017.